Drug Profile
PMK S005
Alternative Names: PMK-N01GI2; PMK-S005Latest Information Update: 01 Feb 2018
Price :
$50
*
At a glance
- Originator PharmaKing
- Class Antiulcers
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Gastric ulcer
- No development reported Gastritis
Most Recent Events
- 08 Dec 2017 Pharmaking completes a phase-II trial in Gastric ulcer in South Korea (PO) (NCT02342470)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Gastritis(In volunteers) in South Korea (PO)
- 01 Sep 2014 Phase-II clinical trials in Gastric ulcer (Prevention, Recurrent) in South Korea (PO)